Dr. Olivier Larochelle – Oncologist / Hematologist | Québec, QC

Dr. Olivier Larochelle is a highly skilled Medical Oncologist and Hematologist, offering expert care in the diagnosis and systemic treatment of both solid tumors and hematologic malignancies. Practicing at CHU Quebec in Québec, QC, he is part of a dedicated healthcare team committed to providing compassionate and comprehensive care. His practice adheres to the standards and ethical guidelines established by the Collège des médecins du Québec (CMQ), ensuring that patients receive safe, evidence-based treatment. Dr. Larochelle offers a multidisciplinary approach to manage complex cases involving cancer and blood disorders, with a focus on improving patient outcomes and quality of life for adults with suspected or diagnosed conditions.

He completed his medical degree in 2011 and has been practicing as a Medical Oncologist and Hematologist for over 13 years. His extensive postgraduate training includes specialized certification in Medical Oncology and Hematology, equipping him with the latest knowledge and techniques in cancer care and blood disorder management. Throughout his career, he has dedicated himself to continuous learning and staying current with emerging therapies and research advancements.

Dr. Larochelle’s clinical philosophy emphasizes personalized, evidence-based care delivered within a multidisciplinary team setting. He is committed to supporting his patients and their families through complex treatment journeys, offering clear communication and compassionate guidance. Fluent in French, he strives to ensure that language is not a barrier to understanding and engaging in the care process. His dedication extends to advancing research and integrating innovative treatments to provide the best possible outcomes for patients across Québec.

Dr. Olivier Larochelle has expertise in managing a wide range of conditions, including:

Common Cancers (Solid Tumors) Treated

• Brain & Central Nervous System (CNS) Tumors (Primary & Metastatic - Medical Oncology aspects): Malignant tumors of the brain and spinal cord, where medical oncologists may manage chemotherapy or targeted therapies as part of a multidisciplinary team.
• Colorectal Cancer (Colon & Rectal Cancer): Cancer that starts in the colon or rectum, often managed with surgery, chemotherapy, radiation (for rectal), and targeted therapies.
• Breast Cancer (Early Stage, Locally Advanced, Metastatic): Malignant tumors developing in the cells of the breast, managed with various therapies including hormonal, chemo, targeted agents, and immunotherapy.

Benign Hematologic (Non-Cancerous Blood) Disorders Managed

• Sickle Cell Disease & Thalassemia Syndromes: Inherited disorders affecting the structure or production of hemoglobin, leading to various complications.
• Hereditary Hemochromatosis & Other Iron Overload States: Genetic or acquired conditions leading to excessive iron accumulation in the body, requiring management to prevent organ damage.
• Immune Thrombocytopenia (ITP): An autoimmune disorder characterized by a low number of platelets, leading to an increased risk of bleeding.

Hematologic Malignancies (Blood Cancers) Treated

• Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL): A type of cancer that starts from white blood cells (lymphocytes) in the bone marrow, typically slow-growing.
• Chronic Myeloid Leukemia (CML): A type of cancer that starts in certain blood-forming cells of the bone marrow, often managed with targeted therapies.
• Hodgkin Lymphoma: A cancer of the lymphatic system, part of the immune system, characterized by the presence of Reed-Sternberg cells.

This list provides examples of common conditions treated and is not exhaustive. Cancer and blood disorders are complex, and treatment is highly individualized. For personalized advice, please discuss your specific situation with Dr. Olivier Larochelle or your referring physician.

• Management of Myelodysplastic Syndromes (MDS): Diagnosis and treatment of bone marrow failure disorders, including supportive care, growth factors, and disease-modifying therapies.
• Bone Marrow Aspiration & Biopsy (Performance or Interpretation): Performing or interpreting samples from bone marrow aspirations and biopsies to diagnose blood disorders and cancers.
• Treatment of Various Solid Tumors: Specialized care for a wide range of cancers such as breast, lung (NSCLC, SCLC), colorectal, prostate, melanoma, ovarian, uterine, cervical, bladder, kidney, pancreatic, stomach, esophageal, head & neck (non-surgical aspects), brain tumors (non-surgical aspects), and sarcomas.
• Diagnosis & Management of Multiple Myeloma, Waldenström's Macroglobulinemia & Other Plasma Cell Dyscrasias: Specialized care for cancers arising from plasma cells, utilizing novel agents, chemotherapy, and supportive care, including stem cell transplant coordination.
• Cancer Survivorship Care & Long-Term Follow-Up: Developing individualized follow-up care plans for cancer survivors, focusing on surveillance for recurrence, management of late effects of treatment, and promoting wellness.
• Comprehensive Oncologic & Hematologic Consultation: In-depth evaluation of medical history, review of diagnostic imaging and pathology, cancer staging (if applicable), and development of personalized treatment plans for various cancers and blood disorders.
• Peripheral Blood Smear Review & Advanced Cytomorphology: Expert microscopic examination of blood cells to identify abnormalities and aid in diagnosis.

Note: This list provides a general overview of services offered in Medical Oncology and Hematology (Cancer and Blood Disorders). Treatment plans are highly individualized. Dr. Larochelle provides a wide array of diagnostic, therapeutic, and supportive care options tailored to each patient's specific condition and needs. Please discuss with Dr. Larochelle or your healthcare team for details relevant to your care.

All medical services and treatments are provided in accordance with the standards of practice set by the Collège des médecins du Québec (CMQ) and relevant cancer care guidelines. A referral is required.

Dr. Larochelle practices at CHU Quebec, situated in the areas near central Québec. The facility is easily accessible via nearby public transit options, making it convenient for patients coming from various parts of the city. The facility is wheelchair accessible to accommodate patients with mobility needs. Parking is available at the site, providing added convenience for those arriving by car. The location is close to local points of interest, offering a comfortable and accessible environment for patients and their families seeking specialized cancer and blood disorder care.

Are consultations and treatments with Dr. Larochelle, an Medical Oncologist and Hematologist, covered by Régie de l'assurance maladie du Québec (RAMQ) in QC?

Medically necessary consultations, diagnostic tests (like biopsies, imaging reviews), chemotherapy, immunotherapy, targeted therapies, radiation therapy planning and delivery, and management of blood disorders by a licensed Medical Oncologist and Hematologist such as Dr. Larochelle are generally covered by Régie de l'assurance maladie du Québec (RAMQ) in QC when a referral from a family doctor or another specialist is in place. Specific drug coverage for newer therapies can vary by provincial formularies and may require special authorization. It's always recommended to discuss coverage specifics with Régie de l'assurance maladie du Québec (RAMQ), Dr. Larochelle's office, the hospital's patient financial services, or the cancer care navigation services at the treatment facility.

Do I need a referral to see Dr. Larochelle, an Medical Oncologist and Hematologist?

Yes, a referral from your family physician or another specialist is almost always required to see an Medical Oncologist and Hematologist like Dr. Larochelle for assessment or treatment of cancer or significant hematological conditions. This ensures that your primary care provider is involved in your care continuum and that you are directed to the most appropriate specialist for your specific situation. Cancer care programs often have centralized intake systems that manage referrals to ensure timely access.

What is targeted therapy in cancer treatment?

Targeted therapy uses drugs or other substances to identify and attack specific types of cancer cells with less harm to normal cells. These therapies work by targeting specific genes or proteins found in cancer cells or cells related to cancer growth, like blood vessel cells. Genetic testing of the tumor is often done to see if a targeted therapy is likely to be effective. Dr. Larochelle can explain if targeted therapy is an option for your cancer.

How will treatment decisions be made for my condition by Dr. Larochelle?

Treatment decisions in oncology and hematology are highly personalized and made collaboratively. Dr. Larochelle will consider many factors, including the type and stage of your cancer or blood disorder, your overall health, genetic markers of the disease (if applicable), current treatment guidelines, and importantly, your personal preferences and values. Often, cases are discussed in multidisciplinary team meetings (tumor boards) with other specialists to ensure a comprehensive approach. You will be an active participant in this decision-making process.

CHU Quebec
11 Côte du Palais
Québec, QC G1R 2J6

Phone: (418) 525-4444

The facility is wheelchair accessible.

Dr. Larochelle is a licensed Medical Oncologist and Hematologist regulated by the Collège des médecins du Québec (CMQ) under the Medical Act in QC. A referral from a family physician or other specialist is required for most consultations and treatments under the provincial health plan.

Verify registration with the Collège des médecins du Québec (CMQ): https://www.cmq.org/en/directory/physicians?number=11682